Hainan Poly Pharm: Announcement regarding the company and related parties receiving the 'Administrative Penalty Decision'
Hainan Poly Pharm: Announcement of resolutions from the 30th meeting of the 4th board of directors.
Hainan Poly Pharm: Announcement of the progress for the company's application for comprehensive credit limit from banks.
Hainan Poly Pharm: Announcement of Resolutions of the Nineteenth Meeting of the Fourth Supervisory Committee.
Hainan Poly Pharm: Verification opinion on Hainan Poly Pharm's temporary supplement of working capital using part of the raised funds in idle named by Haitong Securities Co., Ltd.
Hainan Poly Pharm: Announcement on the Temporary Supplement of Working Capital with Some Unused Raised Funds
Hainan Poly Pharm: Announcement on the approval of clinical trials for the injectable innovative drug PLAT001.
Hainan Poly Pharm: Erratum to the resolution of the twenty-ninth meeting of the fourth board of directors
Hainan Poly Pharm: Statement and Commitment of Independent Director Candidate - Director Li Jianqiang
Hainan Poly Pharm: Statement and Commitment of Independent Director Nominee
Hainan Poly Pharm: Announcement of Resolutions Passed at the 29th Meeting of the 4th Board of Directors.
Hainan Poly Pharm: Haitong Securities Co., Ltd. on the tracking report of Hainan Poly Pharm Co., Ltd. for the year 2023.
Hainan Poly Pharm: Haitong Securities Co., Ltd.'s Special On-site Inspection Report on Hainan Poly Pharm Co., Ltd.
Hainan Poly Pharm: Announcement of resolutions passed at the 28th meeting of the 4th board of directors.
Hainan Poly Pharm: Announcement Regarding Abnormal Fluctuations in Stock Trading
Hainan Poly Pharm: Announcement regarding the company and related parties receiving the "Notice of Administrative Punishment Prior to Notification."
Hainan Poly Pharm: Haitong Securities Co., Ltd.'s verification opinion on the deposit and use of funds raised by Hainan Poly Pharm Co., Ltd. in 2023.
Hainan Poly Pharm: Announcement on the Reminder of Special Verification or Audit Report for Delayed Disclosure of Accounting Errors Correction
Hainan Poly Pharm: 2023 Social Responsibility Report
Hainan Poly Pharm: Special explanation on the non-operational funds occupation and other related funds transactions.
No Data